TrialClinical and experimental immunology2013

Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy.

A A Herasimtschuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.